Seed Funding Essentials: What Early-Stage Biotech Investors Actually Want

About this session

Raising your first significant capital is one of the most challenging milestones for early-stage biotech founders. The seed landscape has become increasingly competitive, with investors demanding more data, clearer paths to value inflection, and stronger teams before committing. This panel brings together leading seed-stage VCs to share what it takes to build a compelling story, which investors to target and when, and the common pitfalls that derail promising fundraises.

Speakers

• 

  Nnenna Ohaka-Akpalaba

  Partner & Investment Reporter · BioXconomy

  Moderator

• 

  Olga Danilchanka

  Partner, MRL Ventures Fund · Merck

  Panelist

• LR

  Laura Rodriguez

  Partner · Invivo Capital

  Panelist

• 

  Giulia Vestri

  Partner · Claris Ventures

  Panelist